You have 9 free searches left this month | for more free features.

Once-daily Simultaneous Modulated Accelerated Radiotherapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Cell Lung Cancer Trial in Guangzhou (q.d. RT, b.i.d.RT, etoposide and cisplatin)

Unknown status
  • Small Cell Lung Cancer
  • q.d. RT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Jan 25, 2021

Esophageal Cancer Trial in Shantou (Radiotherapy with simultaneous modulated accelerated boost, Standard dose radiotherapy, PF)

Recruiting
  • Esophageal Cancer
  • Radiotherapy with simultaneous modulated accelerated boost
  • +2 more
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Dec 27, 2021

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (SMART, DDP, S-1)

Completed
  • Esophageal Squamous Cell Carcinoma
  • SMART
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Sep 2, 2020

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Toripalimab, Paclitaxel-albumin, Nedaplatin)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Oct 25, 2022

Soft Tissue Sarcoma Trial in Florence (RT)

Recruiting
  • Soft Tissue Sarcoma
  • RT
  • Florence, Fi, Italy
    AOU Careggi
Feb 27, 2023

Esophageal Tumors Trial in Shantou (SMART, PF)

Completed
  • Esophageal Neoplasms
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Dec 27, 2021

Uterine Cervical Tumors, Chemoradiotherapy, Adjuvant Chemo Trial in Liuzhou (paclitaxel combined with platinum)

Recruiting
  • Uterine Cervical Neoplasms
  • +2 more
  • paclitaxel combined with platinum
  • Liuzhou, Guangxi, China
    the Fourth Affiliated Hospital of Guangxi Medical University
Feb 16, 2023

Rectal Cancer Trial (Trifluridine/Tipiracil, intensity-modulated radiotherapy)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Jul 27, 2023

Breast Cancer, DCIS Trial in Canada (APBI: 30 Gy, APBI: 27.5 Gy)

Active, not recruiting
  • Breast Cancer
  • DCIS
  • APBI: 30 Gy
  • APBI: 27.5 Gy
  • Barrie, Ontario, Canada
  • +9 more
Apr 4, 2022

Rectal Tumors Trial in Nanning (Tislelizumab, Capecitabine, Oxaliplatin)

Recruiting
  • Rectal Neoplasms
  • Nanning, Guangxi, China
    First Affiliated Hospital of Guangxi Medical University
Aug 27, 2023

Breast Cancer Trial in Worthington, Fargo, Sioux Falls (IMRT/VMAT-Based Accelerated Partial Breast Irradiation)

Recruiting
  • Breast Cancer
  • IMRT/VMAT-Based Accelerated Partial Breast Irradiation
  • Worthington, Minnesota
  • +2 more
Nov 11, 2022

Bladder Cancer Trial in Seoul (hypo-IMRT)

Recruiting
  • Bladder Cancer
  • hypo-IMRT
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jul 6, 2022

Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • IMRT
  • Nivolumab
  • Atlanta, Georgia
  • +3 more
Jan 10, 2023

Breast Cancer Trial in Brussels, Dendermonde (Tomotherapy)

Completed
  • Breast Cancer
  • Tomotherapy
  • Brussels, Belgium
  • +2 more
Jul 19, 2022

Lymphedema Trial in New York (Intensity-modulated radiation therapy (IMRT))

Active, not recruiting
  • Lymphedema
  • Intensity-modulated radiation therapy (IMRT)
  • New York, New York
    Laura and Issac Perlmutter Cancer Center
Jul 7, 2022

Breast Cancer, Radiation Toxicity Trial in Ghent (Radiotherapy)

Completed
  • Breast Cancer
  • Radiation Toxicity
  • Radiotherapy
  • Ghent, Oost-Vlaanderen, Belgium
  • +1 more
Jan 3, 2023

Prostate Cancer Trial in Brussels (MR-guided RT)

Recruiting
  • Prostate Cancer
  • MR-guided RT
  • Brussels, Belgium
    Department of Radiotherapy, UZ Brussel, Vrije Universiteit Bruss
May 18, 2022

Non Small Cell Lung Cancer, Brain Metastases Trial in Nanchang (molecular targeted therapies, Brain Radiotherapy)

Unknown status
  • Non Small Cell Lung Cancer
  • Brain Metastases
  • molecular targeted therapies
  • Brain Radiotherapy
  • Nanchang, Jiangxi, China
    The Second Afiliated Hospital of Nanchang University
Dec 9, 2019

Esophagus Cancer, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (radiation, drug, other, procedure)

Recruiting
  • Esophagus Cancer
  • +2 more
  • Intensity Modulated Radiation Therapy
  • +9 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 6, 2022

Brain Metastases Trial in Vancouver (whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric

Active, not recruiting
  • Brain Metastases
  • whole brain radiotherapy (WBRT) and a simultaneous integrated boost (SIB) using volumetric modulated arc therapy
  • Vancouver, British Columbia, Canada
    BC Cancer Agency - Vancouver Centre
Sep 17, 2021

Oropharynx Cancer Trial in Pittsburgh (procedure, other, radiation, drug)

Recruiting
  • Oropharynx Cancer
  • therapeutic conventional surgery
  • +5 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 4, 2022

Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)

Not yet recruiting
  • Hypopharyngeal Cancer
  • Cisplatin/Nedaplatin, albumin paclitaxel
  • (no location specified)
May 5, 2023

Liver Cancer, Liver Transplant; Complications, Hepatocellular Carcinoma Trial in Shanghai (radiation, combination product, drug)

Not yet recruiting
  • Liver Cancer
  • +4 more
  • intensity-modulated radiotherapy
  • +5 more
  • Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Apr 20, 2022

Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant

Completed
  • The Primary Study Metric is Progression-free Survival (PFS)
    • (no location specified)
    Jun 28, 2023

    Locally Advanced Cervical Carcinoma Trial (Hypofractionation)

    Not yet recruiting
    • Locally Advanced Cervical Carcinoma
    • Hypofractionation
    • (no location specified)
    Jun 25, 2022